Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
$0.00
$0.00
$0.16
$73K-0.0760,924 shsN/A
Hero Technologies Inc. stock logo
HENC
Hero Technologies
$0.00
$0.00
$0.00
$50K1.2108 shsN/A
HSTC
HST Global
$0.00
$0.39
$0.00
$1.10
$23K-1.48450 shsN/A
NEPTF
Neptune Wellness Solutions
$0.02
$0.00
$0.12
$63K-3.133,683 shs192 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
0.00%0.00%0.00%0.00%+200.00%
Hero Technologies Inc. stock logo
HENC
Hero Technologies
0.00%0.00%0.00%0.00%0.00%
HSTC
HST Global
0.00%0.00%-99.87%-99.95%-99.96%
NEPTF
Neptune Wellness Solutions
0.00%0.00%0.00%-53.33%+1,399,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
Hero Technologies Inc. stock logo
HENC
Hero Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
HSTC
HST Global
N/AN/AN/AN/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
0.00
N/AN/AN/A
Hero Technologies Inc. stock logo
HENC
Hero Technologies
0.00
N/AN/AN/A
HSTC
HST Global
0.00
N/AN/AN/A
NEPTF
Neptune Wellness Solutions
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
$2.66M0.00N/AN/AN/ANaN
Hero Technologies Inc. stock logo
HENC
Hero Technologies
N/AN/AN/AN/AN/AN/A
HSTC
HST Global
N/AN/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
$52.62M0.00N/AN/A($91.90) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
-$33.33MN/A0.00N/AN/AN/AN/AN/AN/A
Hero Technologies Inc. stock logo
HENC
Hero Technologies
-$540KN/A0.00N/AN/AN/AN/AN/AN/A
HSTC
HST Global
-$150K-$0.02N/AN/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
-$60.46M-$106.72N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
N/AN/AN/AN/AN/A
Hero Technologies Inc. stock logo
HENC
Hero Technologies
N/AN/AN/AN/AN/A
HSTC
HST Global
N/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
N/A
Hero Technologies Inc. stock logo
HENC
Hero Technologies
N/A
HSTC
HST Global
N/A
NEPTF
Neptune Wellness Solutions
11.72%

Insider Ownership

CompanyInsider Ownership
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
35.20%
Hero Technologies Inc. stock logo
HENC
Hero Technologies
0.21%
HSTC
HST Global
65.82%
NEPTF
Neptune Wellness Solutions
5.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Generex Biotechnology Co. stock logo
GNBT
Generex Biotechnology
15122.06 million79.09 millionNot Optionable
Hero Technologies Inc. stock logo
HENC
Hero Technologies
1456.69 million455.73 millionNot Optionable
HSTC
HST Global
157.77 million19.75 millionNot Optionable
NEPTF
Neptune Wellness Solutions
1304.53 million4.30 millionN/A

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Generex Biotechnology stock logo

Generex Biotechnology OTCMKTS:GNBT

Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene in patients with breast cancer and prostate cancer. In addition, it develops, manufactures, and distributes rapid point-of-care in-vitro medical diagnostics for infectious diseases, such as human immunodeficiency virus, tuberculosis, malaria, hepatitis B, hepatitis C, syphilis, and others; and test kits and cassettes for testing infectious diseases, as well as Excellagen, a wound conforming gel. Further, the company is developing immunotherapeutic products and vaccines; and extracellular matrix hydrogel solution, a tissue engineered therapy for the treatment of Ulcerative Colitis. Additionally, it manufactures and sells foot and ankle surgical kits that include plates, screws, and tools; and distributes surgical supplies, orthopedic implants, artificial joints, and biologics, medical devices, and regenerative medicine products. It also serves as the general partner of the Management Services Organization. Generex Biotechnology Corporation was founded in 1983 and is headquartered in Miramar, Florida. On April 23, 2022, an involuntary petition for liquidation under Chapter 7 was filed against Generex Biotechnology Corporation in the U.S. Bankruptcy Court for the Southern District of Florida. On June 6, 2022, the involuntary petition was approved by the Court.

Hero Technologies stock logo

Hero Technologies OTCMKTS:HENC

Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company is based in Dover, Delaware.

HST Global OTCMKTS:HSTC

$0.0004 0.00 (0.00%)
As of 08/1/2025

HST Global, Inc., operates as an integrated health and wellness biotechnology company in the United States. The company develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer and other life threatening diseases. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancer and or/ life threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.

Neptune Wellness Solutions OTC:NEPTF

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.